Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Am J Kidney Dis. 2014 Apr 2;63(6):1007–1018. doi: 10.1053/j.ajkd.2014.01.436

Fig 3.

Fig 3

The difference between the P30 (99.6% CI) of the CKD-EPI or the MDRD Study equation and each of the alternative equations in subgroups by organ [Kidney, Liver, Lung, Heart, Pancreas, and Multiple organs(Heart/Kidney, Heart/Liver, Kidney/Liver, Kidney/Lung, Kidney/Pancreas, Lung/Liver or Lung/Herat)]

A significant global p value (≤0.004) indicates that the difference in the performance of the CKD-EPI (upper panels) or the MDRD Study equation (lower panels) and the alternative equations is different across studies. A difference of >0 indicates that the P30 of the alternative equation is less than the CKD-EPI or the MDRD Study equation. If the lower margin of the 99.6% CI is above 0, then the alternative equation is inferior; if the margin includes 0, then the alternative equation is similar. For the difference in P30, only the values that are >−20% and < 60% are shown for ease of representation.

Interaction P values represent 4 categories; P≤0.004, P>0.004–0.01, P>0.01–0.05, and P>0.05

*Equations that had transplant recipients in the development cohort

HHS Vulnerability Disclosure